Lorenz Muller
Corporate Officer/Principal bei MILESTONE PHARMACEUTICALS INC.
Vermögen: 238 761 $ am 31.03.2024
Profil
Lorenz Muller is currently the Chief Commercial Officer at Milestone Pharmaceuticals, Inc. He previously worked as the Executive Director-Thrombosis at Daiichi Sankyo, Inc. from 2008 to 2015, Vice President-Marketing & Healthcare Outcomes at CV Therapeutics, Inc. from 2001 to 2011, and Vice President-Marketing at EXACT Sciences Corp.
from 2016 to 2017.
Mr. Muller received his undergraduate and graduate degrees from Massachusetts Institute of Technology and his MBA from Harvard Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.04.2023 | 133 386 ( 0,25% ) | 238 761 $ | 31.03.2024 |
Aktive Positionen von Lorenz Muller
| Unternehmen | Position | Beginn |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Corporate Officer/Principal | 01.10.2017 |
Ehemalige bekannte Positionen von Lorenz Muller
| Unternehmen | Position | Ende |
|---|---|---|
| EXACT SCIENCES CORPORATION | Sales & Marketing | 01.07.2017 |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Corporate Officer/Principal | 01.12.2015 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Sales & Marketing | 02.05.2011 |
Ausbildung von Lorenz Muller
| Massachusetts Institute of Technology | Graduate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| EXACT SCIENCES CORPORATION | Health Technology |
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |
